Article

Wired.comWired.com on 2020-06-17 23:38

The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine

So far, no studies have shown that the antimalarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks.

Related news